Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Acta Endocrinologica

• Publication date

  1977-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1530/ACTA.0.0850650PMID 325982
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hormone blood levels in patients with prostatic carcinoma and their relation to the type of carcinoma growth differentiation.

  1977cited by this paper
• Plasma sex hormone-binding globulin binding capacity in benign prostatic hypertrophy and prostatic carcinoma: comparison with an age dependent rise in normal human males.

  1977cited by this paper
• The effect of ACTH on plasma testosterone and androstenedione concentrations in patients with prostatic carcinoma.

  1976cited by this paper
• Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy.

  1976cited by this paper
• Total and free testosterone in plasma of hypo- and agonadal men.

  1975cited by this paper
• Endocrine changes in male sexual deviants after treatment with anti-androgens, oestrogens or tranquillizers.

  1975cited by this paper
• Dissociation of testosterone from plasma protein during superfusion of slices from human prostate.

  1975cited by this paper
• Mode of action of progesterone, gestonorone capronate (Depostat) and cyproterone acetate (Androcur) on the metabolism of testosterone in human prostatic adenoma: in vitro and in vivo investigations.

  1975cited by this paper
• Plasma estradiol concentrations and effect of HCG on plasma estradiol and testosterone in normal subjects and patients with endocrine disorders.

  1975cited by this paper
• The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity.

  1975cited by this paper
• The determination in human males of specific testosterone and 5aplha-dihydrotestosterone binding to sex hormone binding globulin by a differential dissociation technique.

  1974cited by this paper
• Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens.

  1974cited by this paper
• Regulation of the activities of the enzymes involved in the metabolism of steroid hormones in rat liver: the effect of 19-nortestosterone and the influence of cyproterone acetate on the action of testosterone and 5 alpha-dihydrotestosterone.

  1974cited by this paper
• THE TSH, FSH AND PROLACTIN RESPONSES TO CONTINUOUS INFUSIONS OF TRH AND THE EFFECTS OF OESTROGEN ADMINISTRATION IN NORMAL MALES

  1974cited by this paper
• Regulation of plasma oestrogens in normal adult males. II. Response of oestradiol, oestrone, testosterone and cortisol to dexamethasone and ACTH administration.

  1974cited by this paper
• Effect of cyproterone acetate on sperm concentration, seminal fluid volume, testicular cytology and levels of plasma and urinary ICSH, FSH and testosterone in normal men.

  1973cited by this paper
• Competitive ligand-binding assay for measurement of sex hormone-binding globulin (SHBG).

  1973cited by this paper
• Age related changes and interrelationships between plasma testosterone, oestradiol and testosterone-binding globulin in normal adult males.

  1973cited by this paper
• Effects of Testosterone Oenanthate on Plasma Concentrations of Thyroxine, Cortisol, Testosterone and Hormone Binding Proteins in Patients with Hypogonadism

  1973cited by this paper
• The influence of serum on the uptake, conversion and action of dihydrotestosterone in rat prostate glands in organ culture.

  1972cited by this paper
• The influence of serum on uptake, conversion and action of testosterone in rat prostate glands in organ culture.

  1972cited by this paper
• A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma.

  1972cited by this paper
• Studies of the protein binding of dihydrotestosterone (17-beta-hydroxy-5 alpha-androstan-3 one) in human plasma (in different physiological conditions and effect of medroxyprogesterone) (17-hydroxy-6 alpha-methyl-4 pregnene-3,20 dione 17-acetate).

  1972cited by this paper
• Plasma testosterone levels in patients with prostatic carcinoma before and after treatment.

  1968cited by this paper
• [The effect of orchidectomy on the excretion of testosterone, 17-ketosteroids, estrogens, pregnanediol, 17-hydroxycorticosteroids and gonadotropins in urine].

  1965cited by this paper

• Sex hormone-binding globulin and its critical role in prostate cancer: A comprehensive review.

  2024cites this paper
• A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen.

  2020cites this paper
• Does baseline total testosterone improve the yielding of prostate cancer screening?

  2012cites this paper
• Aromatase Activity and Bone Loss in Men

  2011cites this paper
• Aromatase activity and bone loss.

  2011cites this paper
• Feeding Orange Pulp Improved Bone Quality in a Rat Model of Male Osteoporosis

  2009cites this paper
• Klinische, hormonale, histologische und chromosomale Untersuchungen beim Klinefelter‐Syndrom *

  2009cites this paper
• Successful treatment of prostatic cancer with the orally active depot estrogen ethinylestradiol sulfonate (Turisteron).

  2009cites this paper
• Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa).

  2008cites this paper
• Rôle émergent des oestrogènes dans le cancer de la prostate : sulfate d'oestrone : marqueur de l’agressivité tumorale

  2007cites this paper
• The hair follicle as an estrogen target and source.

  2006cites this paper
• Estrogen in men: effects on bone accrual, maintenance and prevention of bone loss

  2006cites this paper
• A direct approach to the estimation of the origin of oestrogens and androgens in elderly men by comparison with hormone levels in postmenopausal women.

  2005cites this paper
• Immunocytochemical technique for detection of prolactin (PRL) and grwoth hormone (GH) in hyperplastic and neoplastic lesions of dog prostate and mammary gland

  2004cites this paper
• The changes in the binding capacity of testosterone-oestradiol binding globulin (TeBG) following castration and DES-D administration in patients with prostatic carcinoma

  2004influential citation
• Treatment of advanced prostatic cancer with anti-androgens alone and a combination of anti-androgen with anti-prolactine — A pilot study

  2004cites this paper
• Effect of cyproterone/acetate (SH-714) on plasma prolactin in patients with prostatic cancer

  2004cites this paper
• Role of the pituitary gland in experimental hormonal induction and prevention of benign prostatic hyperplasia in the dog

  2004cites this paper
• Aromatase activity and bone homeostasis in men.

  2004cites this paper
• The importance of oestrogens in males

  2003cites this paper
• Clinical review 134: The endocrinology of prostate cancer.

  2001cites this paper
• Epidemiología del cáncer de próstata

  2001cites this paper
• Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review

  2000cites this paper
• Estradiol causes a dose‐dependent stimulation of prostate growth in castrated beagle dogs

  2000cites this paper
• Hormonal predictors of prostate cancer: a meta-analysis.

  2000cites this paper
• A new window on a molecular doorway.

  1999cites this paper
• Pretreatment plasma testosterone and estradiol levels in patients with locally advanced or metastasized prostatic cancer

  1999cites this paper
• Steroid hormones and cancer: IV. Prostate cancer.

  1997cites this paper
• Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia.

  1996cites this paper
• Regulation of sex hormone binding globulin and insulin-like growth factor binding protein-1.

  1996cites this paper
• Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.

  1995cites this paper
• Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.

  1993cites this paper
• Effect of orchidectomy on serum concentrations of testosterone and dihydrotestosterone in patients with prostatic cancer.

  1992cites this paper
• Physical activity and risk of prostatic cancer among college alumni.

  1992cites this paper
• Use of cyproterone acetate in prostate cancer.

  1991cites this paper
• Biochemical profiles and hormone receptors in prostate cancer

  1991cites this paper
• Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.

  1991cites this paper
• Enzymes of Androgen Formation and Degradation in the Human Prostate

  1990cites this paper
• Monthly cyproterone acetate in the treatment of hirsute women: clinical and laboratory effects.

  1990cites this paper
• A prospective, population-based study of androstenedione, estrogens, and prostatic cancer.

  1990cites this paper
• The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances.

  1990cites this paper
• Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response.

  1989cites this paper
• Human serum steroid-binding proteins and malignancy (review).

  1989cites this paper
• Testosterone-estradiol binding globulin (TeBG) in hirsute patients treated with cyproterone acetate (CPA) and percutaneous estradiol.

  1989cites this paper
• Urinary oestrogen excretion in benign prostatic hyperplasia and prostatic cancer.

  1989cites this paper
• Übersicht über die biologischen Grundlagen der Hormontherapie des Prostatakarzinoms

  1989cites this paper
• Endocrine effects of oestrogen withdrawal in long-term treated patients with prostatic adenocarcinoma.

  1988cites this paper
• Microsomal effects of cyproterone acetate and flutamide in rat testis.

  1988cites this paper
• Sex Steroid‐Binding Protein in Nonendocrine Diseases

  1988cites this paper
• Carcinoma of the prostate: pathology, staging, and treatment.

  1988cites this paper
• The etiopathogenesis of prostatic cancer with special reference to environmental factors.

  1988cites this paper
• Prolactin and luteinizing hormone‐releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer

  1988cites this paper
• Relationship of testosterone, sex hormone binding globulin, and calculated free testosterone to subsequent clinical progress in patients with carcinoma of the prostate treated with bilateral orchidectomy or estrogens

  1988cites this paper
• Physiology of the Testosterone‐Binding Globulin in Man

  1988cites this paper
• Drug-Induced Changes in Prolactin Secretion

  1988cites this paper
• Effects of Human Chorionic Gonadotropin, Androgens, Adrenocorticotropin Hormone, Dexamethasone and Hyperprolactinemia on Plasma Sex Steroid‐Binding Protein a

  1988cites this paper
• Cancer of the prostate: endocrine factors.

  1987cites this paper
• [The role of tissue steroids in benign hyperplasia and prostate cancer].

  1987cites this paper
• Treatment of advanced prostatic cancer.

  1987cites this paper
• 10-Jahres-Ergebnisse einer randomisierten Prospektivstudie beim metastasierten Prostatakarzinom

  1987cites this paper
• Sinn und Unsinn von Therapiekombinationen beim fortgeschrittenen Prostatakarzinom

  1987cites this paper
• Überblick über die therapeutischen Möglichkeiten des fortgeschrittenen Prostatakarzinoms

  1987cites this paper
• Serum steroid levels in intact and endocrine ablated BALB/c nude mice and their intact littermates.

  1986cites this paper
• Free testosterone in carcinoma of the prostate

  1986cites this paper
• Correlation of pretreatment plasma levels of estradiol and sex‐hormone‐binding globulin‐binding capacity with clinical stage and survival of patients with prostatic cancer

  1986cites this paper
• Some effects of treatment with ethinyl oestradiol with or without polyoestradiol phosphate in patients with prostatic carcinoma.

  1986cites this paper
• [Cancer of the prostate: estrogen therapy].

  1986cites this paper
• Effect of oestrogen or cyproterone acetate treatment on adrenocortical function in prostate carcinoma patients.

  1986cites this paper
• Intratissular androgens in benign prostatic hyperplasia and prostatic cancer.

  1986cites this paper
• Evidence for Modulation of Melatonin Secretion in Men With Benign and Malignant Tumors of the Prostate: Relationship With the Pituitary Hormones

  1985cites this paper
• Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine.

  1985cites this paper
• The effect of cyproterone and gonadotrophins on the adrenal gland of juvenile and adult rats. A morphological and morphometrical study.

  1985cites this paper
• Review: Prostate cancer epidemiology

  1985cites this paper
• Prolactin: Ein Regulator des zytoplasmatischen Androgen-Rezeptors in der Prostata?

  1985cites this paper
• Familial factors affecting prostatic cancer risk and plasma sex‐steroid levels

  1985cites this paper
• Carcinoma of the prostate: relationship of pretreatment hormone levels to survival.

  1984cites this paper
• Hormone levels in prostatic fluid from healthy finns and prostate cancer patients.

  1984cites this paper
• The serum steroid transport proteins: biochemistry and clinical significance.

  1984cites this paper
• Binding capacity of testosterone-estradiol-binding globulin (TeBG), total and calculated unbound concentrations of testosterone in patients with carcinoma of the prostate treated with orchidectomy or estrogens

  1983cites this paper
• The clinical significance of steroid hormone measurements in the management of patients with prostatic cancer

  1983cites this paper
• The Relationship Between Benign Prostatic Hyperplasia and Prostatic Carcinoma

  1983cites this paper
• [Treatment of virilized women with intramuscular administration of cyproterone acetate].

  1983cites this paper
• Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer

  1983cites this paper
• [Interdependence between hormonal disorders, staging and degree of malignancy of prostatic gland cancer. 2].

  1983cites this paper
• Hormonal control and rationale for endocrine therapy of prostatic tumours

  1983cites this paper
• Effect of diet on plasma and urinary hormones in South African black men with prostatic cancer.

  1982cites this paper
• Orchiectomy combined with cyproterone acetate or prednisone in the treatment of advanced prostatic carcinoma. A randomized clinical and endocrine study.

  1982cites this paper
• Blood hormone levels related to stages and grades of prostatic cancer

  1982cites this paper
• The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.

  1982cites this paper
• [Clinical study on the prolactin in male. Report 1. The secretion of prolactin in the patients with prostatic cancer and hypogonadal men (author's transl)].

  1982cites this paper
• Abnormal levels of plasma hormones in men with prostate cancer: Evidence toward a “two‐disease” theory

  1982cites this paper
• Nuclei of stroma: Site of highest estrogen concentration in human benign prostatic hyperplasia

  1982cites this paper
• The levels of the male serum and seminal fluid prolactin in oligospermia and azoospermia.

  1981cites this paper
• [Endocrinological studies on prostatic carcinoma. 1. Plasma hormone profiles in patients with prostatic carcinoma (author's transl)].

  1981cites this paper
• [Studies on testicular endocrinological function by estimation of plasma testosterone, estradiol and estradiol testosterone ratio. Studies on testicular function; report 9 (author's transl)].

  1981cites this paper
• Changes in male salivary testosterone concentration with age.

  1981cites this paper
• Hormonal pattern in prostatic cancer. I. Correlation with local extent of tumour, presence of metastases and grade of differentiation.

  1981cites this paper
• The immunocytochemical detection of protein hormones in human prostatic tissues

  1981cites this paper
• Hormonal pattern in prostatic cancer

  1981cites this paper
• Clinical Markers in Prostatic Cancer

  1981cites this paper